Human Genetics Market Research Report: By Instrument (Accessories, Device), Method (Prenatal, Molecular, Cytogenetic, Presymptomatic), Application (Forensic Research, Cancer, Cardiovascular Diseases), and End User (Hospitals) – Global Forecast Till 2027
ID: MRFR/LS/0243-HCR | February 2021 | Region: Global | 80 pages
Market scenario
Genetics is nothing but the study of genes, their functions and effects. Molecular genetics, developmental genetics, population genetics and quantitative genetics, and human genetics are various types of genetic studies. Human genetics is the study of inheritance in human beings, i.e., it is the study of inheritance of characteristics in children from parents. It includes the study of gene expression, gene structure, mutation analysis, cytogenetics and genomic imaging, genome structure and organization, genetic and physical mapping, disease association studies, molecular diagnostics, genetics of complex diseases, epistatic interactions, and various other concepts. It also helps to determine various genetic factors responsible for diseases. It offers various advantages such as identification and diagnosis and treatment of various diseases such as cancer, cardiovascular diseases, and other genetic diseases.
The global human genetics market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe. Furthermore, the growing awareness about genetic diseases, increasing investments in research and development, and rising government support fuel the market growth. However, various factors restrain the growth of the market such as higher cost of instruments and lack of skilled professionals.
Global Human Genetics Market is expecting a healthy growth at a CAGR of 11.5% during the forecast period.
Intended Audience
- Research and Development (R&D) Companies
- Genetics & Genomic Industries
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Figure 1- Global Human Genetics Market, by Region
Source: Annual reports, press release, white paper, company presentation
Segmentation
The global human genetics market is segmented by instruments, methods, applications, and end-users.
On the basis of instruments, it is segmented into accessories and devices.
On the basis of methods, it is segmented into prenatal, molecular, cytogenetic, and presymptomatic.
On the basis of applications, it is segmented into forensic research, cancer, cardiovascular diseases, diabetes, genetic diseases, and others.
On the basis of end-users, it is segmented into hospitals, forensic laboratories, research centers, and others.
Market Assessment
Source; World Health Organization (WHO, white paper, company presentation, annual reports
Regional analysis
America is the largest market for human genetics owing to the development in the diagnostics and medical technology and extensive use of new technologies in genetics. Additionally, the presence of key players in the market also fuels the market growth. The U.S. is the largest market for human genetics with an increase in the number of studies in genetics and its importance in healthcare.
The European market for human genetics is driven by the rising prevalence of different chronic genetic diseases and increasing government support for research and development activities. In Germany, being the largest market, the growth is governed by the rising focus on research activities by major market players in the field of genetics and technological advancement.
In Asia Pacific, the market is fueled by the increasing awareness about research in genetic diseases and steady rise in the prevalence of genetic diseases. Major countries contributing to the market growth are China, Japan, and India due to increasing availability of research facilities and presence of skilled workforce such as research scientists and others. Additionally, the increasing number of research institutes focusing on the diagnosis and treatment of genetic diseases with the help of human genetics and increasing availability of funds for research in the field of genetics support the growth of the market.
The Middle East and Africa holds the least share in the global human genetics market and shows a steady growth due to the rising demand for healthcare services and research activities, poor economic condition, and less development in medical facilities, especially, in Africa.
Key players
Some of the major players in the global human genetics market are Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 11.5% (2017-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Instrument, Method, Application and End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.). |
| Key Market Opportunities | Increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe |
| Key Market Drivers |
|
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Human Genetics Market, by Method
6.1 Introduction
6.2 Cytogenetic
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Molecular
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Presymptomatic
6.4.1 Market Estimates & Forecast, 2020-2027
6.5 Prenatal
6.5.1 Market Estimates & Forecast, 2020-2027
7. Global Human Genetics Market, by Product
7.1 Introduction
7.2 Consumables
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Devices
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Accessories
7.4.1 Market Estimates & Forecast, 2020-2027
8. Global Human Genetics Market, by Application
8.1 Introduction
8.2 Research
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Diagnostic
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Forensic Science
8.4.1 Market Estimates & Forecast, 2020-2027
9. Global Human Genetics Market, by End-User
9.1 Introduction
9.2 Hospital and Clinics
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Diagnostic Centers
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Research Centers
9.4.1 Market Estimates & Forecast, 2020-2027
9.5 Forensic Departments
9.5.1 Market Estimates & Forecast, 2020-2027
10. Global Human Genetics Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Agilent Technologies
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 Bode Technology
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.3 GE Healthcare
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.4 Illumina
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.5 LGC Forensics
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Orchid Cellmark, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Promega Corporation
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Human Genetics Industry
14 Appendix
LIST OF TABLES
Table 1 Human Genetics Industry Synopsis, 2020-2027
Table 2 Global Human Genetics Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Human Genetics Market, by Region, 2020-2027, (USD Million)
Table 4 Global Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 5 Global Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 6 Global Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 7 Global Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 8 North America Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 9 North America Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 10 North America Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 11 North America Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 12 US Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 13 US Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 14 US Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 15 US Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 16 Canada Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 17 Canada Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 18 Canada Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 19 Canada Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 20 South America Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 21 South America Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 22 South America Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 23 South America Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 24 Europe Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 25 Europe Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 26 Europe Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 27 Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 28 Western Europe Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 29 Western Europe Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 30 Western Europe Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 31 Western Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 32 Eastern Europe Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 33 Eastern Europe Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 34 Eastern Europe Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 35 Eastern Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 36 Asia Pacific Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 37 Asia Pacific Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 38 Asia Pacific Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 39 Asia Pacific Human Genetics Market, by End-User, 2020-2027, (USD Million)
Table 40 Middle East & Africa Human Genetics Market, by Method, 2020-2027, (USD Million)
Table 41 Middle East & Africa Human Genetics Market, by Product, 2020-2027, (USD Million)
Table 42 Middle East & Africa Human Genetics Market, by Application, 2020-2027, (USD Million)
Table 43 Middle East & Africa Human Genetics Market, by End-User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Human Genetics Market
Figure 3 Segmentation Market Dynamics for Human Genetics Market
Figure 4 Global Human Genetics Market Share, by Product 2016
Figure 5 Global Human Genetics Market Share, by Application 2016
Figure 6 Global Human Genetics Market Share, by End-User, 2016
Figure 7 Global Human Genetics Market Share, by Region, 2016
Figure 8 North America Human Genetics Market Share, by Country, 2016
Figure 9 Europe Human Genetics Market Share, by Country, 2016
Figure 10 Asia Pacific Human Genetics Market Share, by Country, 2016
Figure 11 Middle East & Africa Human Genetics Market Share, by Country, 2016
Figure 12 Global Human Genetics Market: Company Share Analysis, 2016 (%)
Figure 13 AGILENT TECHNOLOGIES: Key Financials
Figure 14 AGILENT TECHNOLOGIES: Segmental Revenue
Figure 16 AGILENT TECHNOLOGIES: Geographical Revenue
Figure 17 Bode Technology: Key Financials
Figure 18 Bode Technology: Segmental Revenue
Figure 19 Bode Technology: Geographical Revenue
Figure 20 GE Healthcare: Key Financials
Figure 21 GE Healthcare: Segmental Revenue
Figure 22 GE Healthcare: Geographical Revenue
Figure 23 QIAGEN N.V.: Key Financials
Figure 24 QIAGEN N.V.: Segmental Revenue
Figure 25 QIAGEN N.V.: Geographical Revenue
Figure 26 Orchid Cellmark, Inc.: Key Financials
Figure 27 Orchid Cellmark, Inc.: Segmental Revenue
Figure 28 Orchid Cellmark, Inc.: Geographical Revenue
Figure 29 LGC Forensics: Key Financials
Figure 30 LGC Forensics: Segmental Revenue
Figure 31 LGC Forensics: Geographical Revenue